LDLR, low density lipoprotein receptor, 3949

N. diseases: 336; N. variants: 1434
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 AlteredExpression disease BEFREE This study provides evidence that a common variant in CCDC93, encoding a protein involved in recycling of the LDLR, is associated with lower LDL-c levels, lower risk of MI and cardiovascular mortality. 31630160 2020
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Familial hypercholesterolemia (FH) is an inherited disease of lipoprotein metabolism caused by a defect in the LDL receptor (LDLR) leading to severe hypercholesterolemia, and associated with an increased risk of coronary heart disease and myocardial infarction. 31061510 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 Biomarker disease BEFREE Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. 31097165 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE This study enrolled PMI patients (n = 225) and detected the mutations in their FH-associated genes (LDLR, APOB, PCSK9, LDLRAP1) by Sanger sequencing. 30971288 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE In good agreement with previous studies in patients with familial hypercholesterolaemia, our study in the Japanese general population showed that rare variants in LDLR and PCSK9 were associated with the onset age of MI by altering LDL-cholesterol levels. 29802317 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 Biomarker disease BEFREE As for prospective cohort studies, many inconsistent reports on the association of LDL-C and ASCVD were disregarded when drafting the Statement, reports with and without genetic factors related to LDL receptor function should be analyzed separately, and the term ASCVD in the Statement is used inappropriately because myocardial infarction and cerebral infarction differ in their association with LDL-C. As for RCTs, clinical reports on statins published before and after the implementation of new regulations affecting clinical trials (2004/2005) should not both be included in meta-analyses because the evaluated efficacy of statins changed markedly, and the irreversible adverse effects of statins need to be evaluated more rigorously now that their mechanisms have been elucidated. 29353277 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 AlteredExpression disease BEFREE By applying this approach to missense alleles identified through cohort-level exome sequencing in the low-density lipoprotein receptor (LDLR) we are able to distinguish rare alleles that predispose to familial hypercholesterolemia and myocardial infarction from alleles without obvious impact on LDLR levels or functions. 28470529 2017
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Importantly, considering experimental data refined the risk of rare LDLR allele carriers from 4.5- to 25.3-fold for high LDL-C, and from 2.1- to 20-fold for early-onset myocardial infarction. 25647241 2015
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE At low-density lipoprotein receptor (LDLR), carriers of rare non-synonymous mutations were at 4.2-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). 25487149 2015
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 AlteredExpression disease BEFREE Bioinformatic analysis of this differential gene-set for associated pathways revealed 1) increasing disease severity in AMI patients is associated with a decreased expression of genes involved in the developmental epithelial-to-mesenchymal transition pathway, and 2) modulation of cholesterol transport genes that include ABCA1, CETP, APOA1, and LDLR is associated with clinical outcome. 24801707 2014
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE High frequency LDLR mutations (related to familial high cholesterol) predict myocardial infarction in approximately50% of individuals. 21472782 2011
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE The Apo E isoform, and 2 common low-density lipoprotein receptor variants (rs1433099 and rs6511720) influence MI risk in this multiethnic sample. 20031563 2009
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Their early work on the LDL receptor explained a genetic cause of heart attacks and led to new ways of thinking about cholesterol metabolism. 19299327 2009
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE SNP-level associations included three SNPs with MI (one LDLR, two LIPC) and two SNPs with stroke (one CETP, one LDLR). 18622260 2008
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. 12646194 2003
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Although early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infarction, the techniques available for determining the number of the functional LDL receptor molecules are difficult to carry out and expensive. 11050659 2000
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Except for certain polymorphisms in lipid genes (i.e., apolipoprotein E [apo E]) or rare genetic variations (i.e., LDL receptor), which have a causal effect on both the intermediate (LDL-cholesterol level in plasma) and the clinical phenotypes (CAD/MI), the role of most gene polymorphisms is controversial or unknown. 11258599 2000
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Patients with LDLR defects had a significantly higher risk of myocardial infarction, coronary artery bypass graft, positive coronary angiography, atherosclerotic plaques in the carotid arteries and CAD (p<0.01) than patients with FDB. 9360938 1996
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 GeneticVariation disease BEFREE Although early identification of individuals carrying the defective gene could be useful in reducing the risk of atherosclerosis and myocardial infarction, the available techniques for determining the number of the functional LDL receptor molecules are not sufficiently accurate. 2904255 1989
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 Biomarker disease BEFREE Familial hypercholesterolemia produces a premature inherited form of myocardial infarction, whereas, atherosclerosis with myocardial infarction, seen in advanced age, relates more closely to environmental factors such as smoking, diet, etc. 2812210 1989
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.200 Biomarker disease HPO